B. Grimaldi et al., CHARACTERIZATION OF 5-HT(6) RECEPTOR AND EXPRESSION OF 5-HT(6) MESSENGER-RNA IN THE RAT-BRAIN DURING ONTOGENIC DEVELOPMENT, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 393-400
We have determined the pharmacological characteristics of the rat 5-ht
(6) receptor stably expressed in CHO cells. Moreover, using RT-PCR exp
eriments the in vivo expression of the gene encoding this receptor was
studied in rat at Various embryonic days (ED) starting from ED10 to b
irth (PN0) and at post-natal days (PN) up to PN36 The pharmacological
analysis of the [H-3]5-HT binding in stably transfected CHO cells expr
essing rat 5-ht(6) receptors revealed the presence of a single class o
f high affinity saturable binding sites for 5-HT corresponding to an a
ffinity constant: Kd = 27.2+/-3.4 nM. This receptor also exhibited a h
igh affinity for a number of typical and atypical antipsychotics, tric
yclic antidepressant drugs and ergot alkaloids. In stably transfected
CHO cells, serotonin elicited a potent stimulation of adenylyl cyclase
activity which was blocked by antipsychotic and antidepressant drugs.
These results confirm the hypothesis that 5-ht(6) receptors may corre
spond to an important target for atypical antipsychotics and reveal an
original pharmacological profile for this receptor. The study of the
ontogeny of the 5-ht(6) mRNA in rat developing brain showed that 5-ht(
6) mRNA were first detectable with a high level on ED12, slightly decr
eased up to ED17 and then remained stable at high level until the adul
t age. The ontogenetic pattern of 5-ht(6) mRNA expression appeared to
correlate with the occurence of the first cell bodies of serotonergic
neurons; the early expression of 5-ht(6) mRNA and the fact that this r
eceptor is positively coupled to the production of cAMP may suggest a
role for 5-ht(6) receptor in the early growth process involving the se
rotonergic system.